Tissue Inhibitor of Metalloproteinases-1 Induces a Pro-tumourigenic Increase of MiR-210 in Lung Adenocarcinoma Cells and Their Exosomes

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2014 Sep 30

PMID 25263437

Citations 94

Authors

H Cui

B Seubert

E Stahl

H Dietz

U Reuning

L Moreno-Leon

M Ilie

P Hofman

H Nagase

B Mari

A Kruger

Affiliations

Soon will be listed here.

Abstract

Tissue inhibitor of metalloproteinases-1 (TIMP-1) recently emerged as a pro-metastatic factor highly associated with poor prognosis in a number of cancers. This correlation seemed paradox as TIMP-1 is best described as an inhibitor of pro-tumourigenic matrix metalloproteinases. Only recently, TIMP-1 has been revealed as a signalling molecule that can regulate cancer progression independent of its inhibitory properties. In the present study, we demonstrate that an increase of both exogenous and endogenous TIMP-1 led to the upregulation of miR-210 in a CD63/PI3K/AKT/HIF-1-dependent pathway in lung adenocarcinoma cells. TIMP-1 induced P110/P85 PI3K-signalling and AKT phosphorylation. It also led to increase of HIF-1α protein levels positively correlating with HIF-1-regulated mRNA expression and upregulation of the microRNA miR-210. Downstream targets of miR-210, namely FGFRL1, E2F3, VMP-1, RAD52 and SDHD, were decreased in the presence of TIMP-1. Upon the overexpression of TIMP-1 in tumour cells, miR-210 was accumulated in exosomes in vitro and in vivo. These exosomes promoted tube formation activity in human umbilical vein endothelial cell (HUVECs), which was reflected in increased angiogenesis in A549L-derived tumour xenografts. Activation and elevation of PI3K, AKT, HIF-1A and miR-210 in tumours additionally confirmed our in vitro data. This new pro-tumourigenic signalling function of TIMP-1 may explain why elevated TIMP-1 levels in lung cancer patients are highly correlated with poor prognosis.

Citing Articles

Biogenesis and functional implications of extracellular vesicles in cancer metastasis.

Sekar S, Srikanth S, Mukherjee A, Gopalakrishnan A, Wanjari U, Vellingiri B Clin Transl Oncol. 2024; .

PMID: 39704958 DOI: 10.1007/s12094-024-03815-8.

The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering.

Zhu B, Xiang K, Li T, Li X, Shi F Cell Commun Signal. 2024; 22(1):512.

PMID: 39434182 PMC: 11492701. DOI: 10.1186/s12964-024-01870-w.

Harnessing exosomes as cancer biomarkers in clinical oncology.

Ghosh S, Rajendran R, Mahajan A, Chowdhury A, Bera A, Guha S Cancer Cell Int. 2024; 24(1):278.

PMID: 39113040 PMC: 11308730. DOI: 10.1186/s12935-024-03464-5.

VMP1: a multifaceted regulator of cellular homeostasis with implications in disease pathology.

Tong J, Wang Q, Gao Z, Liu Y, Lu C Front Cell Dev Biol. 2024; 12:1436420.

PMID: 39100095 PMC: 11294092. DOI: 10.3389/fcell.2024.1436420.

Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases.

Xu C, Jiang C, Li Z, Gao H, Xian J, Guo W MedComm (2020). 2024; 5(8):e660.

PMID: 39015555 PMC: 11247338. DOI: 10.1002/mco2.660.

References

Jung K, Liu X, Chirco R, Fridman R, Kim H . Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 2006; 25(17):3934-42. PMC: 1560352. DOI: 10.1038/sj.emboj.7601281. View

Kopitz C, Gerg M, Bandapalli O, Ister D, Pennington C, Hauser S . Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res. 2007; 67(18):8615-23. DOI: 10.1158/0008-5472.CAN-07-0232. View

Schelter F, Halbgewachs B, Baumler P, Neu C, Gorlach A, Schrotzlmair F . Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α. Clin Exp Metastasis. 2010; 28(2):91-9. DOI: 10.1007/s10585-010-9360-x. View

Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V . Prognostic significance of TIMP-1 in non-small cell lung cancer. Anticancer Res. 2011; 31(11):4031-8. View

Rauvala M, Puistola U, Turpeenniemi-Hujanen T . Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor. Gynecol Oncol. 2005; 99(3):656-63. DOI: 10.1016/j.ygyno.2005.07.009. View

Ghajar C, Peinado H, Mori H, Matei I, Evason K, Brazier H . The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013; 15(7):807-17. PMC: 3826912. DOI: 10.1038/ncb2767. View

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

Taube M, Liu X, Fridman R, Kim H . TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein. Oncogene. 2006; 25(21):3041-8. DOI: 10.1038/sj.onc.1209336. View

Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S . Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292(5516):468-72. DOI: 10.1126/science.1059796. View

10.

Park J, Tan H, Datta A, Lai R, Zhang H, Meng W . Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010; 9(6):1085-99. PMC: 2877972. DOI: 10.1074/mcp.M900381-MCP200. View

11.

Xiao F, Qiu H, Zhou L, Shen X, Yang L, Ding K . WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation. Glycobiology. 2013; 23(5):524-35. DOI: 10.1093/glycob/cwt004. View

12.

Murphy G . Tissue inhibitors of metalloproteinases. Genome Biol. 2011; 12(11):233. PMC: 3334591. DOI: 10.1186/gb-2011-12-11-233. View

13.

De Lorenzo M, Ripoll G, Yoshiji H, Yamazaki M, Thorgeirsson U, Alonso D . Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1. In Vivo. 2003; 17(1):45-50. View

14.

Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, Sakai Y . MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem. 2010; 286(1):420-8. PMC: 3013001. DOI: 10.1074/jbc.M110.170852. View

15.

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View

16.

Ilie M, Lassalle S, Long-Mira E, Hofman V, Zangari J, Benaim G . In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF (V600E) mutation status and together with hypoxia-related proteins predicts aggressive behavior. Virchows Arch. 2013; 463(3):437-44. DOI: 10.1007/s00428-013-1453-x. View

17.

Kucharzewska P, Christianson H, Welch J, Svensson K, Fredlund E, Ringner M . Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013; 110(18):7312-7. PMC: 3645587. DOI: 10.1073/pnas.1220998110. View

18.

Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K . miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther. 2007; 7(2):255-64. PMC: 3233968. DOI: 10.4161/cbt.7.2.5297. View

19.

Lu Y, Liu S, Zhang S, Cai G, Jiang H, Su H . Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression. Mol Cells. 2011; 31(3):225-30. PMC: 3932703. DOI: 10.1007/s10059-011-0023-9. View

20.

Stetler-Stevenson W . Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal. 2008; 1(27):re6. PMC: 2493614. DOI: 10.1126/scisignal.127re6. View